7C Solarparken AG (HRPK)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 1.725 |
|---|---|
| 52-week range | 1.512 – 1.955 |
| Return, 1 month / 3 months | −5.7% / −1.4% |
| Return, 1 year / 3 years | +7.8% / −45.6% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 26.5% |
| Worst drawdown (1 year) | -16.9% |
| Average daily value traded | 0.08M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
7C Solarparken AG owns and operates solar photovoltaic power plants, mainly in Germany, and produces electricity that it feeds into the public grid. Its customers are essentially the electricity market and grid operators, who pay for the power generated under regulated feed-in arrangements and direct supply contracts. The company is based in Bayreuth, Germany, and focuses on running and maintaining its portfolio of ground-mounted and rooftop solar installations.
On this site 7C Solarparken AG appears as a stock on the XETRA Stock Exchange (Germany), code HRPK, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
7C Solarparken AG (HRPK) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 1.725 on 23 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 220 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.8% and over the last three months it fell 1.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -0.8% | ||
| From 52-week high | -11.5% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.4% | ||
| 6-month return | -2.0% | ||
| 12-month return, skipping the last month | 14.4% | ||
| Stability (higher is calmer) | 82 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.9% | ||
| Liquidity | 41 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.08M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.5% |
|---|---|
| 1 month | −5.7% |
| 3 months | −1.4% |
| 6 months | −2.0% |
| 1 year | +7.8% |
| 3 years | −45.6% |
| 5 years | −53.6% |
Signals
| 50-day / 200-day average | 1.771 / 1.738 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.045 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Jun 2024 | EUR 0.0600 |
| 13 Jun 2023 | EUR 0.1200 |
| 22 Jul 2022 | EUR 0.1100 |
| 22 Jul 2021 | EUR 0.1100 |
| 20 Jul 2020 | EUR 0.1100 |
| 10 Jun 2019 | EUR 0.1100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.